GlassScriptPhysician profile
Brigid Killelea
NPI 1548422561
$30,687.98
in general payments reported to CMS, 2019-2025
7 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2021: $745 · 2022: $6,961 · 2023: $2,035 · 2024: $5,088 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $7,425 · Food and Beverage: $1,917 · Entertainment: $29.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,454.17 |
| Travel and Lodging | $7,425.26 |
| Food and Beverage | $1,917.40 |
| Entertainment | $29.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $14,250.46 | 2019-2025 | Magseed, Magtrace, Sentimag |
| Abbvie INC. | $11,374.92 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $4,027.50 | 2025 | Enhertu |
| Leica Microsystems INC. | $382.02 | 2022-2025 | Mammotome Elite |
| Molli Surgical (US) INC | $308.65 | 2022 | |
| Allergan, INC. | $182.63 | 2021 | |
| Medtronic, INC. | $161.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigid Killelea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.